[HTML][HTML] Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future

D Akhoundova, MA Rubin - Cancer Cell, 2022 - cell.com
Next-generation DNA sequencing technology has dramatically advanced clinical oncology
through the identification of therapeutic targets and molecular biomarkers, leading to the …

Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future

D Akhoundova, MA Rubin - Cancer cell, 2022 - pubmed.ncbi.nlm.nih.gov
Next-generation DNA sequencing technology has dramatically advanced clinical oncology
through the identification of therapeutic targets and molecular biomarkers, leading to the …

Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future.

D Akhoundova Sanoyan, MA Rubin - Cancer cell, 2022 - boris.unibe.ch
Next-generation DNA sequencing technology has dramatically advanced clinical oncology
through the identification of therapeutic targets and molecular biomarkers, leading to the …

[HTML][HTML] Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future

D Akhoundova, MA Rubin - Cancer Cell, 2022 - Elsevier
Next-generation DNA sequencing technology has dramatically advanced clinical oncology
through the identification of therapeutic targets and molecular biomarkers, leading to the …

Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future.

D Akhoundova, MA Rubin - Cancer Cell, 2022 - europepmc.org
Next-generation DNA sequencing technology has dramatically advanced clinical oncology
through the identification of therapeutic targets and molecular biomarkers, leading to the …

[HTML][HTML] Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future

D Akhoundova, MA Rubin - Cancer Cell, 2022 - cell.com
Next-generation DNA sequencing technology has dramatically advanced clinical oncology
through the identification of therapeutic targets and molecular biomarkers, leading to the …